Prostate specific antigen testing in family practice: a cross sectional survey of self-reported rates of and reasons for testing participation and risk disclosure

[1] Baade PD(2009)International epidemiology of prostate cancer: geographical distribution and secular trends Mol Nutr Food Res 53 171-184

[2] Youlden DR(2003)Progress in cancer screening practices in the United States: results from the 2000 National Health Interview Survey Cancer 97 1528-1540

[3] Krnjacki LJ(2011)Prostate-specific antigen testing rates remain low in UK general practice: a cross-sectional study in six English cities BJU Int 108 1402-1408

[4] Swan J(2004)Rates of prostate-specific antigen testing in general practice in England and Wales in asymptomatic and symptomatic patients: a cross-sectional study BJU Int 94 51-56

[5] Breen N(2010)American cancer society guideline for the early detection of prostate cancer: update 2010 CA-Cancer J Clin 60 70-98

[6] Coates RJ(2012)Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up J Natl Cancer Inst 104 125-132

[7] Rimer BK(2012)Prostate-cancer mortality at 11 years of follow-up N Engl J Med 366 981-990

[8] Lee NC(2010)Screening for prostate cancer: systematic review and meta-analysis of randomised controlled trials BMJ 341 c4543-30

[9] Williams N(2011)Cancer screening in the United States, 2011 CA-Cancer J Clin 61 8-134

[10] Hughes LJ(2012)Screening for prostate cancer: U.S. preventive services task force recommendation statement Ann Intern Med 157 120-1123

[1] Baade PD(2009)International epidemiology of prostate cancer: geographical distribution and secular trends Mol Nutr Food Res 53 171-184

[2] Youlden DR(2003)Progress in cancer screening practices in the United States: results from the 2000 National Health Interview Survey Cancer 97 1528-1540

[3] Krnjacki LJ(2011)Prostate-specific antigen testing rates remain low in UK general practice: a cross-sectional study in six English cities BJU Int 108 1402-1408

[4] Swan J(2004)Rates of prostate-specific antigen testing in general practice in England and Wales in asymptomatic and symptomatic patients: a cross-sectional study BJU Int 94 51-56

[5] Breen N(2010)American cancer society guideline for the early detection of prostate cancer: update 2010 CA-Cancer J Clin 60 70-98

[6] Coates RJ(2012)Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up J Natl Cancer Inst 104 125-132

[7] Rimer BK(2012)Prostate-cancer mortality at 11 years of follow-up N Engl J Med 366 981-990

[8] Lee NC(2010)Screening for prostate cancer: systematic review and meta-analysis of randomised controlled trials BMJ 341 c4543-30

[9] Williams N(2011)Cancer screening in the United States, 2011 CA-Cancer J Clin 61 8-134

[10] Hughes LJ(2012)Screening for prostate cancer: U.S. preventive services task force recommendation statement Ann Intern Med 157 120-1123